US biopharma: 221 drugs now in R&D for diabetes, related…
US biopharmaceutical research companies are currently developing a total of 221 new medicines for the treatment of diabetes and related conditions, according to new industry data. - News - PharmaTimes
by Lyne Taylor
https://www.pharmatimes.com/news/us_biopharma_221_drugs_now_in_r_and_d_for_diabetes,_related_conditions_976242